DM
Therapeutic Areas
Xennials Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NTX-301 | Platinum-resistant/refractory advanced ovarian cancer, bladder cancer, and other solid tumors | Phase 1/2 |
| NTX-301 + Temozolomide | High-grade Glioma (IDH1 mutated or Wild-Type) | Phase 1/2 (Planned Cohort) |